1. Home
  2. PTHL vs NCPL Comparison

PTHL vs NCPL Comparison

Compare PTHL & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTHL
  • NCPL
  • Stock Information
  • Founded
  • PTHL 1998
  • NCPL 1984
  • Country
  • PTHL China
  • NCPL United States
  • Employees
  • PTHL N/A
  • NCPL N/A
  • Industry
  • PTHL
  • NCPL Investment Managers
  • Sector
  • PTHL
  • NCPL Finance
  • Exchange
  • PTHL Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • PTHL 8.8M
  • NCPL 9.2M
  • IPO Year
  • PTHL 2024
  • NCPL N/A
  • Fundamental
  • Price
  • PTHL $0.60
  • NCPL $1.93
  • Analyst Decision
  • PTHL
  • NCPL
  • Analyst Count
  • PTHL 0
  • NCPL 0
  • Target Price
  • PTHL N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • PTHL 122.3K
  • NCPL 68.3K
  • Earning Date
  • PTHL 01-01-0001
  • NCPL 12-15-2025
  • Dividend Yield
  • PTHL N/A
  • NCPL N/A
  • EPS Growth
  • PTHL N/A
  • NCPL N/A
  • EPS
  • PTHL N/A
  • NCPL N/A
  • Revenue
  • PTHL $448,196.00
  • NCPL $917,291.00
  • Revenue This Year
  • PTHL N/A
  • NCPL $739.37
  • Revenue Next Year
  • PTHL N/A
  • NCPL N/A
  • P/E Ratio
  • PTHL N/A
  • NCPL N/A
  • Revenue Growth
  • PTHL N/A
  • NCPL N/A
  • 52 Week Low
  • PTHL $0.47
  • NCPL $1.50
  • 52 Week High
  • PTHL $32.00
  • NCPL $8.75
  • Technical
  • Relative Strength Index (RSI)
  • PTHL 36.00
  • NCPL 39.14
  • Support Level
  • PTHL $0.47
  • NCPL $1.94
  • Resistance Level
  • PTHL $0.65
  • NCPL $2.20
  • Average True Range (ATR)
  • PTHL 0.06
  • NCPL 0.17
  • MACD
  • PTHL 0.04
  • NCPL -0.04
  • Stochastic Oscillator
  • PTHL 63.46
  • NCPL 23.07

About PTHL Pheton Holdings Ltd Class A Ordinary Shares

Pheton Holdings Ltd is a healthcare solutions provider dedicated to developing and commercializing treatment software and devices used for brachytherapy. Its proprietary treatment planning system is a type of radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system, FTTPS, is designed to promote the efficiency, accuracy, and safety of brachytherapy. FTTPS is a user-oriented treatment planning system, or TPS, for treating a wide variety of malignant tumors, which can determine the target volume, prescription dose, and dose limitation to protect OARs and produce a safe, effective, and accurate dose distribution plan for brachytherapy for cancer patients.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: